Did You Know?

Editor’s Picks

Latest News

Activity Connection and Zinnia TV Partner to Advance Person-Centered Care in Senior Living Through Integrated Life Enrichment and Digital Engagement

VANCOUVER, Wash., Jan. 30, 2026 /PRNewswire/ -- Activity Connection and Zinnia TV today announced a strategic partnership to integrate structured...

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (ā€œScilexā€ or the ā€œCompanyā€) (Nasdaq: SCLX), an innovative...

Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA

Company expects up to six-month review period per FDA guidelinesĀ  New longer-term clinical data demonstrating durable positive brain biochemical and...

Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value

New Taipei City, Taiwan, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the ā€œCompanyā€ or ā€œJyong Biotechā€),...

New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) inĀ Advanced HER2-Positive Breast Cancer

- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed...

error: Content is protected !!